Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “buy” rating restated by analysts at Needham & Company LLC in a research report issued on Wednesday, Benzinga reports. They presently have a $32.00 target price on the stock. Needham & Company LLC’s price objective would indicate a potential upside of 31.58% from the company’s […]
Opaleye Management Inc. lowered its position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) by 9.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 735,000 shares of the company’s stock after selling 75,000 shares during the period. Rhythm Pharmaceuticals makes […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) was down 3.5% during trading on Friday . The company traded as low as $15.81 and last traded at $15.88. Approximately 232,315 shares were traded during mid-day trading, a decline of 64% from the average daily volume of 640,093 shares. The stock had previously closed at $16.45. Wall […]
Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) have earned a consensus recommendation of “Moderate Buy” from the eight analysts that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price […]